Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series A brings $1.3mm to Euclises Pharmaceuticals; $700k added

Executive Summary

Euclises Pharmaceuticals Inc. (oncology) raised $1.3mm through its Series A round led by Cultivation Capital. Life sciences accelerator BioGenerator also participated, along with Missouri Technology Corp., ABC Laboratories, the St. Louis Port Authority’s Helix Fund, and seed investors the St. Louis Arch Angels. BioGenerator and St. Louis Arch Angels join the board.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies